Screener
Intellia Therapeutics NTLA PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Prepaid expenses and other current assets | 82,752 | 68,359 |
| Total current assets | 527,832 | 527,711 |
| Marketable securities - noncurrent | 190,595 | 155,250 |
| Property and equipment, net | 15,058 | 17,671 |
| Operating lease right-of-use assets | 85,954 | 105,955 |
| Investments and other assets | 37,725 | 35,540 |
| Total assets | $857,164 | $842,127 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY |
Item 1. Financial Statements
FAQ
- What is Intellia Therapeutics's PP&E (net)?
- Intellia Therapeutics (NTLA) reported PP&E (net) of $15.06M in Q2 2026.
- How has Intellia Therapeutics's PP&E (net) changed year-over-year?
- Intellia Therapeutics's PP&E (net) decreased by 34.0% year-over-year, from $22.81M to $15.06M.
- What is the long-term trend for Intellia Therapeutics's PP&E (net)?
- Over 5 years (2020 to 2025), Intellia Therapeutics's PP&E (net) has grown at a 2.1% compound annual growth rate (CAGR), from $15.94M to $17.67M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Intellia Therapeutics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude